Elevai Labs announces the filing of two innovative patents in collaboration with Yuva Biosciences. These patents support the development of Elevai’s innovative solutions for hair and scalp vitality. Patent Application Serial No 63/664,517, covers the unique and novel combination of Elevai exosomes and Y100, technologies that the inventors believe are synergistic and could allow significantly better results than either technology used alone. The second patent, , Patent Application Serial No 63/664,526, covers the use of exosomes as a unique delivery system while also serving to protect and preserve the molecules being delivered.Elevai Labs is poised to expand the application of their proprietary technologies beyond their current uses. This upcoming product line was recently announced as part of a conference presentation to medical aesthetics professionals by the inventors and scientific co-founders of Elevai Labs and Yuva Biosciences at The Aesthetic Show in Las Vegas, Jordan R. Plews, PhD and Keshav K. Singh, PhD, and the company plans to initiate full-scale marketing of the Elevai S-Series Root Renewal System(TM) in the near future. Given the demonstrated effectiveness of the underlying technologies, the S-Series is expected to attract keen interest from professional providers in the hair and scalp care market.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ELAB:
- Elevai Labs Inc. Files Combination Patents with Yuva Biosciences for Breakthrough Hair and Scalp Care Technology Utilizing YuvaBioⓇ Y100™ Mitochondrial Innovation and Elevai Exosomes™
- Biotech Alert: Searches spiking for these stocks today
- Elevai’s Elevai Skincare announces data results from Elevai Enfinity study
- Elevai Labs Inc. Subsidiary, Elevai Skincare Inc., Announces Positive Data Results with Completion of Clinical Study of Elevai Enfinity™ Topical Exosome Serum
- Elevai Labs Inc. Subsidiary, Elevai Research Inc., Announces Preliminary Positive Research Data Highlighting the Potential of Proprietary Exosome Technology for Skin Health Applications